4-53508003-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001126328.3(LNX1):c.605G>A(p.Arg202Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000341 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126328.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LNX1 | NM_001126328.3 | c.605G>A | p.Arg202Gln | missense_variant | Exon 3 of 11 | ENST00000263925.8 | NP_001119800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LNX1 | ENST00000263925.8 | c.605G>A | p.Arg202Gln | missense_variant | Exon 3 of 11 | 1 | NM_001126328.3 | ENSP00000263925.7 | ||
ENSG00000282278 | ENST00000507166.5 | c.1017+82038C>T | intron_variant | Intron 12 of 23 | 2 | ENSP00000423325.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000841 AC: 21AN: 249812Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135228
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461664Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727106
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.605G>A (p.R202Q) alteration is located in exon 3 (coding exon 2) of the LNX1 gene. This alteration results from a G to A substitution at nucleotide position 605, causing the arginine (R) at amino acid position 202 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at